Dopamine D2R and opioid MOR availability in autism spectrum disorder
Tuomo Noppari, Jouni Tuisku, Lasse Lukkarinen, Pekka Tani, Nina Lindberg, Emma Saure, Hannu Lauerma, Jari Tiihonen, Jussi Hirvonen, Semi Helin, Johan Rajander, Juha Salmi, Lauri Nummenmaa
This study investigates dopamine D2R and opioid MOR receptor availabilities in ASD using PET imaging and finds reduced D2R availability in striatum and nucleus accumbens, and MOR changes in hippocampi and precuneus.
bioRxiv · Apr 9, 2024 · PreprintNeuroscience